CliffBio
small molecule

PREMPHASE (PREMARIN;CYCRIN 14/14)

ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand namePREMPHASE (PREMARIN;CYCRIN 14/14)
Active ingredientESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
Strength0.625MG,0.625MG;N/A,5MG
Dosage formTABLET
RouteORAL-28
ModalitySmall molecule
FDA approvalDecember 1994
Marketing statusDISCN

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.